期刊文献+

超级白细胞介素-6重组慢病毒的构建及其对肝细胞的促增殖作用 被引量:1

The influence of the recombinant lentiviral vectors encoding Hyper-IL-6 on the proliferation of human hepatic cell
原文传递
导出
摘要 目的观察超级白细胞介素-6重组慢病毒对人正常肝细胞L—02的促增殖作用。方法利用慢病毒表达质粒及其包装系统构建超级白细胞介素-6重组慢病毒(FIV—Hyper—IL-6)、IL-6重组慢病毒(FIV-IL-6)和空慢病毒载体(FIV),用嘌呤霉素筛选的方法测定其病毒滴度。将人肝细胞L02分为4组:FIV-Hyper—IL-6组、FIV-IL-6组、FIV组及未感染组,各组分别感染其相应的重组慢病毒,采用四甲基偶氮唑盐法检测其对L-02细胞生长状态的影响;并用RT—PCR法检测重组慢病毒感染L02细胞后产生的急性时相蛋白结合珠蛋白mRNA表达量的变化。应用方差分析进行统计学分析。结果构建出的各重组慢病毒能成功感染靶细胞,嘌呤霉素筛选法测得的各重组慢病毒的病毒滴度均为10^3pfu/ml。病毒颗粒感染L02细胞后48h,细胞的促增殖作用(4值)FIV—Hyper—IL-6组为0.6267±0.0256,FIV—IL-6组、FIV组及未感染组分别为0.5563±0.0112、0.5040±0.0078、0.4790±0.0201,F=41.09,P值均〈0.01,且随着时间的延长,对细胞的促增殖作用有所增加,并于感染后72h达到最高,为0.8000±0.0166。FIV—Hyper—IL-6组细胞结合珠蛋白mRNA吸光度值为0.7030±0.0106,FIV—IL-6组、FIV组及未感染组分别为0.3355±0.0093、0.1143±0.0153、0.1145±0.0076,q=57.5007,P值均〈0.01。结论构建的Hyper-IL-6重组慢病毒能够显著刺激L-02细胞表达结合珠蛋白,对L-02细胞有较强的促增殖作用。 Objective To investigate the effect of Hyper-IL-6 on the proliferation of L-02 cells. Methods The recombinant lentiviral vectors encoding Hyper-IL-6 (FIV-Hyper-IL-6), IL-6 (FIV-IL-6) and the lentiviral (FIV) were prepared using the FIV-based lentiviral vectors and the packaging system. The titer of FIV-Hyper-IL-6, FIV-IL-6 and FIV was tested with puromycin. L-02 cells were infected with FIV-Hyper- IL-6, FIV-IL-6, FIV, or mock-infected. The growth rate of L02 cells was analyzed with MTT at different time points after infection. The changes of Haptoglobin in L-02 cells were analyzed with RT-PCR. Results FIV- Hyper-IL-6, FIV-IL-6 and FIV were successfully constructed, and the titer was 107 pfu/ml. 48 hours after infection, the absorbance of the cells infected with FIV-Hyper-IL-6 was 0.6267 ± 0.0256, and the absorbances of FIV-IL-6 infected cells, FIV infected cells and mock-infected cells were 0.5563 ±0.0112, 0.5040 ± 0.0078 and 0.4790 ±0.0201, respectively. There were significant differences between the FIV-Hyper-IL-6 group and the other groups (F = 41.09, P 〈 0.01). The ratio of the absorbance between haptoglobin mRNA and beta-actin was 0.7030 ± 0.0106, 0.3355 ± 0.0093, 0.1145± 0.0076 and 0.1143 ±0.0153, respectively,in FIV-Hyper-IL-6 infected cells, FIV-IL-6 infected cells, FIV infected cells and mock-infected cells. There were significant differences between the FIV-Hyper-IL-6 group and the others (q = 57.5007, P 〈 0.01). Condusion Compared with IL-6, Hyper-IL-6 is more potent to stimulate proliferation and induce the expression of Haptoglobin in L-02 cells.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2009年第8期615-619,共5页 Chinese Journal of Hepatology
基金 国家自然科学基金(30671866)
关键词 肝细胞 白细胞介素-6 慢病毒属 触珠蛋白类 Hepatocyte Interleukin-6 Lentivirus Haptoglobins
  • 相关文献

参考文献14

  • 1郄春花,秦波.Hyper-白细胞介素-6与肝脏疾病[J].中华肝脏病杂志,2006,14(3):238-240. 被引量:2
  • 2Fulop A K, Pocsik E, Brozik M, et al. Hepatic regeneration induces transient acute phase reaction: systemic elevation of acute phase reactants and soluble cytokine receptors. Cell Biol Int, 2001, 25: 585-592.
  • 3郄春花,秦波,黄爱龙,刘杞,陈国民.Hyper-IL-6融合基因的构建及在真核细胞中的表达[J].细胞与分子免疫学杂志,2006,22(2):141-143. 被引量:5
  • 4Schooltink H, Stoyan T, Lenz D, et al. Structural and functional studies on the human hepatic interleukin-6 receptor. Molecular cloning and overexpression in HepG2 cells. Biochem J, 1991, 277: 659- 664.
  • 5Horton RM, Hunt HD, Ho SN, et al. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene, 1989, 77: 61-68.
  • 6Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol, 2005, 175: 3463-3468.
  • 7Wei LH, Baumann H, Tracy E,et al. Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling. Br J Cancer, 2007, 97: 1513-1522.
  • 8Quaye IK. Haptoglobin,Inflammation and disease. Trans R Soc Trop Med Hyg, 2008, 102: 735-742.
  • 9Kang Y, Xie L, Tran DT, et al. Persistent expression of factor Ⅷ in vivo following nonprimate lentiviral gene transfer. Blood, 2005, 106: 1552-1558.
  • 10Nash KL, Alexander GJ, Lever AM. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes. J Viral Hepat, 2005, 12: 346-356.

二级参考文献24

  • 1Fischer M,Goldschmitt J,Peschel C,et al.A bioactive designer cytokine for human hemtopoietic progenitor cell expansion.Nature Biotechnol,1997,15:142-145.
  • 2Althoff K,Mullberg J,Aasland D,et al.Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins.Biochem J,2001,353(pt3):663-672.
  • 3Boulanger MJ,Chow D,Brevnova EE,et al.Hexameric structure and assembly of theinterleukin-6/IL-6alpha-receptor/gp130 complex.Science,2003,300:2101-2104.
  • 4Rose-John S.Interleukin-6 biology is coordinated by membrane bound and soluble receptors.Acta Biochim Pol,2003,50:603-611.
  • 5Igaz P,Horvath A,Horvath B,et al.Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6;it inhibits TNF production.Immunol Lett,2000,71:143-148.
  • 6Streetz KL,Luedde T,Manns MP,et al.Interleukin-6 and liver regeneration.Gut,2000,47:309-312.
  • 7Rakemann T,Niehof M,Kubicka S,et al.The designer cytokine hyper-intreleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro.J Biol Chem,1999,274:1257-1266.
  • 8Peters M,Blinn G,Jostock T,et al.Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration.Gastroenterology,2000,119:1163 -1171.
  • 9Cressman DE,Greenbaum LE,DeAngelis RA,et al.Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.Science,1996,274:1379-1383.
  • 10Taub R,Greenbaum LE,Peng Y,et al.Transcriptional regulatory signals define cytokines-dependent and independent pathways in liver regeneration.Semin Liver Dis,1999,19:117-127.

共引文献4

同被引文献16

  • 1郄春花,秦波.Hyper-IL-6的结构与生物学功能研究进展[J].中国免疫学杂志,2007,23(3):281-283. 被引量:1
  • 2Fischer M,Goldschmitt J,Peschel et al.A bioactive designer cytokine for human hematopoietic progenitor cell expansion[J].Nature Biotechnology,1997;15:142-145.
  • 3Drucker C,Gewiese J,Malchow S et al.Impact of interleukin-6 classic-and trans-signaling on liver damage and regeneration[J].J Autoimmun,2010;34(1):29-37.
  • 4Cressman D E,Greenbaum L E,Deangelis R A et al.Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice[J].Science,1996;274:1379-1383.
  • 5Male Peters,Guido Blinn,Fian Solem et al.In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6[J].Immunol,1998;161:3575-3581.
  • 6Yeoh GC,Ernst M,Rose-John S,Akhurst B et al.Opposing roles of gp130-mediated STAT-3 and ERK-1/2 signaling in liver progenitor cell migration and proliferation[J].Hepatoology,2007;45(2):486-494.
  • 7Richards P J,Nowell M A,Horiuchi S et al.Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis[J].Arthritis Rheum,2006;54(5):1662-1672.
  • 8Thampi H B S,Manoj G,Leelamma,S et al.Dietary fiber and lipid peroxidation.Effects of dietary fiber on levels of lipids and lipid peroxides in high fat diet[J].Indian J Experimental Biology,1991;29(6):563-567.
  • 9Venditti P,Di M S.Effect of training on antioxidant capacity,tissue damage,and endurance of adult male rats[J].Inter J Sports Medicine,1997;18(7):497-502.
  • 10Delenda C.Lentiviral vectors:optimization of packaging,transduction and gene expression[J].J Gene Med,2004;6(Supple 1):S125-S138.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部